Poems syndrome C90.2

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch


Crow Fukase Syndrome; PEP Syndrome; Shimpo syndrome; Takatsuti Syndrome

This section has been translated automatically.

Acronym for:

  • polyneuropathy
  • Organomegaly
  • Endocrinopathy
  • Monoclonal Gammopathy
  • Skin(skin) changes

The outstanding clinical picture shows a moderately active osteosclerotic multiple myeloma with monoclonal gammopathy associated with chronic demyelinating PNP. Skin lesions are observed in about 70% of patients and may be monitoring signs of the underlying systemic disease.

This section has been translated automatically.

Mainly occurring in middle-aged patients (40-50 years).

Clinical features
This section has been translated automatically.

Diffuse and circumscribed hyperpigmentations, multiple capillary hemangiomas (22-44% of patients; the clinical findings are identical with the findings of"senile angioma"), which are histologically characterized by a glomeruloid structure. Furthermore, diffuse solid swellings of the extremities, scleroderma-like skin thickenings, if necessary sclerodactyly, vasculitis of the small vessels, hypertrichosis and rarely also nail changes(leukonychia) are found.

The organ manifestations that significantly influence the clinical course of POEMS syndrome are defined as follows:

  • Extravascular volume overload (pericardial effusion, ascites - 50 to 70% of patients)
  • Organ megaly (splenomegaly, hepatomegaly in 50% of patients each)
  • Osteosclerotic and/or osteolytic bone lesions (about 20% of patients)
  • Endocrinopathies (diabetes mellitus, hypothyroidism)
  • Sensory polyneuropathies

This section has been translated automatically.

The hemangiomas are characterized by a characteristic histological structure as glomeruloid hemangiomas (reminiscent of glomerula of the kidney).

This section has been translated automatically.

Dermatological symptoms:

  • Hyperpigmentations
  • Hypertrichosis
  • multiple capillary hemangiomas
  • Diffuse, solid swelling of the extremities
  • Scleroderma-like thickening of the skin
  • Sclerodactyly
  • Vasculitis of the small vessels
  • Leukonychie

Organ manifestations:

  • MGUS
  • Extravascular volume overload (pericardial effusion, ascites)
  • Organ megaly (splenomegaly, hepatomegaly, lymphadenopathy)
  • osteosclerotic and/or osteolytic bone lesions (about 20% of patients)
  • endocrinopathies (diabetes mellitus, hypothyroidism)
  • Sensory polyneuropathies

This section has been translated automatically.

Treatment of the underlying disease, radiotherapy, chemotherapy. Cooperation with internists and neurologists.

This section has been translated automatically.

  1. Bardwick PA et al (1989) Plasmacell dyscraisia with polyneurophaty, organmegaly, endocrinopathy, M protein, and skin changes: The POEMS syndrome. Medicine 59: 311-322
  2. Caramaschi P et al (2003) A case of acquired partial lipodystrophy associated with POEMS syndrome. Rheumatology (Oxford). 42: 488-490
  3. Elling E et al (2008) The Schnitzler syndrome: chronic urticaria and monoclonal gammopathy-a autoinflammatory syndrome. JDDG 6: 626-631
  4. Glazebrook K et al (2015) Computed tomography assessment of bone lesions in patients with POEMS syndrome. Eur Radiol 25:497-504
  5. Kang K et al (2003) POEMS syndrome associated with ischemic stroke. Arch Neurol 60: 745-749
  6. Marinho FS et al (2015) CutaneousManifestations in POEMS Syndromes: Case Report and Review. Case Rep Dermatol 7:61-69
  7. Obermoser G et al (2003) Absence of human herpesvirus-8 in glomeruloid haemangiomas associated with POEMS syndrome and Castleman's disease. Br J Dermatol 148: 1276-1278
  8. Schaller M (2001) Improvement of cutaneous manifestations in POEMS syndrome after UVA1 phototherapy. J Am Acad Dermatol 45: 969-970
  9. Scheers C (2002) POEMS syndrome revealed by multiple glomeruloid angiomas. Dermatology 204: 311-313


Please ask your physician for a reliable diagnosis. This website is only meant as a reference.


Last updated on: 29.10.2020